Skip to main content
. Author manuscript; available in PMC: 2014 Apr 2.
Published in final edited form as: Cancer Discov. 2013 Apr 2;3(4):388–398. doi: 10.1158/2159-8290.CD-12-0548

Figure 2. Strategies to provide costimulatory support to CAR-modified T cells.

Figure 2

From upper left: UL, physiological costimulatory ligand display by professional or artificial antigen presenting cells; UR, auto- and trans-costimulation by T cells expressing costimulatory ligands; LR, embedded costimulation provided by second or third generation CARs; LL, redirected costimulation mediated by an antigen-specific chimeric costimulatory receptor (CCR).